Editor’s Note: The home page of the BioNJ website provides an up-to-the-minute headline service where readers can access press releases issued by New Jersey-based biotechnology companies. Go to the “New Jersey Biotechnology Company News” section on the BioNJ home page to read the latest news. Companies wishing to appear in the Biolines Biotechnology Companies in… Read the full article
Biolines September 2011
Membership Update – September 2011
BioNJ welcomes Leerink Swan as a new Diamond Member for 2011: Leerink Swann Founded in 1995, Leerink Swann is recognized as a leading healthcare investment bank to a broad range of institutional, life sciences, corporate, and high-net-worth clients that are positioned to shape the future of healthcare. Leerink Swann’s deep domain knowledge provides its clients… Read the full article
Industry News and Notes – September 2011
Trenton Report Funding Available to Help Life Science Companies Leverage Angel and Venture Fund Investments TRENTON — Governor Chris Christie announced on August 2 that funding is available for life science and technology companies through three programs offered by the New Jersey Economic Development Authority (EDA). The products target emerging companies that have attracted capital… Read the full article
Call for Nominations: The Dr. Sol J. Barer Award for Vision Innovation and Leadership
BioNJ is seeking nominations for its most prestigious award, The Dr. Sol J. Barer Award for Vision, Innovation and Leadership. Named for Sol J. Barer, PhD, the former Chairman and CEO of Celgene Corporation, and presented at BioNJ’s Annual Dinner Meeting, Awards Program and Networking Event, the award recognizes outstanding biotechnology industry business leaders who… Read the full article
From news about Biotech 2011 to the America Invents Act
In this column, I would like to discuss two important developments for the biotechnology industry in New Jersey: The exciting new programs and events taking place at Biotech 2011. The President’s signing of the America Invents Act into law. Biotech 2011 — You spoke. We listened. We have made exciting changes to the structure of… Read the full article